Pages that link to "Q55061445"
Jump to navigation
Jump to search
The following pages link to The metabolism of tamoxifen (I.C.I. 46,474). I. In laboratory animals. (Q55061445):
Displaying 50 items.
- Comparative temporal and dose-dependent morphological and transcriptional uterine effects elicited by tamoxifen and ethynylestradiol in immature, ovariectomized mice (Q33287050) (← links)
- Tamoxifen as the first targeted long-term adjuvant therapy for breast cancer (Q33642104) (← links)
- Chemoprevention of breast cancer by tamoxifen: risks and opportunities (Q34072601) (← links)
- Metabolism of estrogens—natural and synthetic (Q34190969) (← links)
- The binding of [3H]-oestradiol-17 beta in the immature rat uterus during the sequential administration of non-steroidal anti-oestrogens (Q35177982) (← links)
- Peroxidase-mediated dealkylation of tamoxifen, detected by electrospray ionization–mass spectrometry, and activation to form DNA adducts (Q35659643) (← links)
- Clinical pharmacokinetics of endocrine agents used in advanced breast cancer (Q35722575) (← links)
- A study on the effect of a single dose of tamoxifen on uterine hyperaemia and growth in the rat (Q35754976) (← links)
- Physiologically Based Pharmacokinetic Modeling of Tamoxifen and its Metabolites in Women of Different CYP2D6 Phenotypes Provides New Insight into the Tamoxifen Mass Balance. (Q35975826) (← links)
- Evidence for the metabolic activation of non-steroidal antioestrogens: a study of structure-activity relationships (Q36096945) (← links)
- New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer (Q36927087) (← links)
- Selective estrogen receptor modulators and phytoestrogens (Q36984515) (← links)
- Bioanalytical methods for determination of tamoxifen and its phase I metabolites: A review (Q37811317) (← links)
- Tamoxifen. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use. (Q38649722) (← links)
- The development of tamoxifen for breast cancer therapy: a tribute to the late Arthur L. Walpole (Q39524591) (← links)
- Antiestrogens in treatment of breast cancer (Q39624250) (← links)
- Aromatase inhibitors and their use in controlling oestrogen-dependent processes (Q39689545) (← links)
- Tamoxifen: a review of its pharmacological properties and therapeutic use in the treatment of breast cancer (Q39740131) (← links)
- Physiological and pharmacological effects of estrogens in breast cancer (Q39840985) (← links)
- Estrogen and progesterone receptor proteins in breast cancer (Q39841011) (← links)
- Metabolites of tamoxifen in animals and man: Identification, pharmacology, and significance (Q40105171) (← links)
- Nonsteroidal antiestrogens: Their biological effects and potential mechanisms of action (Q40153370) (← links)
- Pharmacokinetics and toxicity testing (Q40182378) (← links)
- Laboratory studies to develop general principles for the adjuvant treatment of breast cancer with antiestrogens: problems and potential for future clinical applications (Q40211096) (← links)
- Effects of oestradiol-17β and tamoxifen on nuclear oestradiol-17β receptors in DMBA-induced rat mammary tumours (Q41259988) (← links)
- Association of tamoxifen biliary excretion rate with prior tamoxifen exposure and increased mdr1b expression (Q42626858) (← links)
- Sensitivity and Proportionality Assessment of Metabolites from Microdose to High Dose in Rats Using LC–MS/MS (Q42807076) (← links)
- Comparative effects of progesterone, norgestrel, norethisterone and tamoxifen on the abnormal uterus of the anovulatory rat. (Q42869057) (← links)
- Monohydroxytamoxifen: An antioestrogen with high affinity for the chick oviduct oestrogen receptor (Q43634735) (← links)
- CYP2D6-mediated catalysis of tamoxifen aromatic hydroxylation with an NIH shift: similar hydroxylation mechanism in chicken, rat and human liver microsomes (Q44353593) (← links)
- A genetically inducible porcine model of intestinal cancer (Q44439656) (← links)
- Quantification of tamoxifen and three metabolites in plasma by high-performance liquid chromatography with fluorescence detection: application to a clinical trial (Q44472490) (← links)
- Evidence for superoxide formation during hepatic metabolism of tamoxifen (Q45126505) (← links)
- Approaches for predicting effects of unintended environmental exposure to an endocrine active pharmaceutical, tamoxifen (Q46679968) (← links)
- Sonic hedgehog from both nerves and epithelium is a key trophic factor for taste bud maintenance. (Q48028230) (← links)
- Growth of separated and recombined neonatal rat uterine luminal epithelium and stroma on extracellular matrix: effects of in vivo tamoxifen exposure. (Q52225507) (← links)
- Tamoxifen Goes Forward Alone (Q54170777) (← links)
- Embryo toxicity of clomiphene citrate on mouse embryos fertilized in vitro and in vivo. (Q54278431) (← links)
- A bioassay for antiestrogenic activity--potential utility in drug development and monitoring effective in vivo dosing (Q54280009) (← links)
- Investigations of droloxifene and other hormonal manipulations on N-nitrosomethylurea-induced rat mammary tumours. 2. Influence on oestrogen receptor (Q67578411) (← links)
- The selective uptake of tamoxifen by human uterine tissue (Q69756770) (← links)
- Effect of monohydroxytamoxifen on mouse mammary tumors (Q70672374) (← links)
- Tamoxifen-induced generalized lipidosis in rats subchronically treated with high doses (Q70986376) (← links)
- High-performance liquid chromatographic determination of clomiphene using post-column on-line photolysis and fluorescence detection (Q70976201) (← links)
- Mechanisms of estrogen and antiestrogen action in mammary cancer (Q71100431) (← links)
- Paired-ion chromatographic analysis of tamoxifen and two major metabolites in plasma (Q71160581) (← links)
- Interaction of [3H] estradiol - and [3H] monohydroxytamoxifen-estrogen receptor complexes with a monoclonal antibody (Q71195773) (← links)
- Comparative pharmacodynamic analysis of TAT-59 and tamoxifen in rats bearing DMBA-induced mammary carcinoma (Q71581725) (← links)
- Determination of tamoxifen and metabolites in human serum by high-performance liquid chromatography with post-column fluorescence activation (Q71688337) (← links)
- Pharmacokinetics of droloxifene in mice, rats, monkeys, premenopausal and postmenopausal patients (Q72797596) (← links)